Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ptc Therapeutics
(NQ:
PTCT
)
32.25
+1.20 (+3.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ptc Therapeutics
< Previous
1
2
3
4
5
6
Next >
Dow Falls Over 100 Points; Analog Devices Posts Upbeat Q2 Earnings
May 24, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.44% to 32,908.94 while the NASDAQ fell...
Via
Benzinga
Why Is Apexigen (APGN) Stock Up 31% Today?
May 24, 2023
Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS).
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Down 22% Today?
May 24, 2023
Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares.
Via
InvestorPlace
Why Is PTC Therapeutics (PTCT) Stock Down 21% Today?
May 24, 2023
PTC Therapeutics (PTCT) stock is taking a beating on Wednesday after the company provided investors with an update on a clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 24, 2023
Via
Benzinga
The Latest Analyst Ratings for PTC Therapeutics
May 08, 2023
Via
Benzinga
PTC Therapeutics's Return On Capital Employed Insights
May 04, 2023
Via
Benzinga
Analyst Expectations for PTC Therapeutics's Future
April 18, 2023
Via
Benzinga
Where PTC Therapeutics Stands With Analysts
March 17, 2023
Via
Benzinga
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 24, 2023
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 24, 2023
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning!
Via
InvestorPlace
Agilent, PTC Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 24, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Looking Into PTC Therapeutics's Return On Capital Employed
February 22, 2023
Via
Benzinga
Earnings Outlook For PTC Therapeutics
February 20, 2023
Via
Benzinga
Expert Ratings for PTC Therapeutics
December 14, 2022
Via
Benzinga
PTC Therapeutics Gets $1B Funding From Blackstone, Shares Fall
October 28, 2022
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
May 23, 2023
From
The Schall Law Firm
Via
Business Wire
PTC Therapeutics Takes Investors On A Ride With A Failed Study, Scrapped Programs, Ousted CFO
May 23, 2023
PTC announced a barrage of news, starting with a failed Phase 3 study.
Via
Investor's Business Daily
Chart Of The Day: PTC Therapeutics
May 18, 2023
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for patients with rare disorders.
Via
Talk Markets
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
May 18, 2023
Needham raised the price target for Dynatrace, Inc. (NYSE: DT) from $52 to $56. Needham analyst James Ricchiuti maintained a Buy rating. Dynatrace shares gained 1.9% to $47.95 in pre-market trading.
Via
Benzinga
Why PTC Therapeutics Could Be Victorious In Its Rare-Disease Battle Against BioMarin Pharmaceuticals
May 17, 2023
The company is working on a treatment for PKU, a disorder that can lead to intellectual disabilities.
Via
Investor's Business Daily
Why did Sarepta Therapeutics Stock Plummet?
March 21, 2023
SRPT stock fell 20% after the FDA changed course on their new DMD treatment approval. The stock remains strong with an encouraging outlook and a mod Buy rating.
Via
MarketBeat
Exposures
Product Safety
7 Nasdaq Stocks to Sell Before They Plunge in 2023
December 05, 2022
While loyalty may be a positive trait in most circumstances, when it comes to Nasdaq stocks to sell, you got to look out for number one.
Via
InvestorPlace
PTC Therapeutics's Return On Capital Employed Overview
November 02, 2022
According to Benzinga Pro data, during Q3, PTC Therapeutics (NASDAQ:PTCT) posted sales of $217.13 million. Earnings were up 28.12%, but PTC Therapeutics still reported an overall loss of $109.31...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 28, 2022
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion.
Via
Benzinga
Earnings Scheduled For April 27, 2023
April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via
Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
October 28, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.